These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22341225)

  • 41. Super-resolution microscopy by nanoscale localization of photo-switchable fluorescent probes.
    Bates M; Huang B; Zhuang X
    Curr Opin Chem Biol; 2008 Oct; 12(5):505-14. PubMed ID: 18809508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using 3D in vitro cell culture models in anti-cancer drug discovery.
    Langhans SA
    Expert Opin Drug Discov; 2021 Aug; 16(8):841-850. PubMed ID: 33823728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantum dot-based mortalin staining as a visual assay for detection of induced senescence in cancer cells.
    Kaul Z; Yaguchi T; Chiura HX; Kaul SC; Wadhwa R
    Ann N Y Acad Sci; 2007 Apr; 1100():368-72. PubMed ID: 17460200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current State-of-the-Art 3D Tissue Models and Their Compatibility with Live Cell Imaging.
    Bardsley K; Deegan AJ; El Haj A; Yang Y
    Adv Exp Med Biol; 2017; 1035():3-18. PubMed ID: 29080127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new approach to assess drug sensitivity in cells for novel drug discovery.
    Mazzarella L; Curigliano G
    Expert Opin Drug Discov; 2018 Apr; 13(4):339-346. PubMed ID: 29415581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recapitulating Tumor Microenvironment Using AXTEX-4DTM for Accelerating Cancer Research and Drug Screening.
    Baru A; Mazumder S; Kundu PK; Sharma S; Das Purkayastha BP; Khan S; Gupta R; Mehrotra Arora N
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):561-571. PubMed ID: 35225469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypoxia-directed drug strategies to target the tumor microenvironment.
    Hay MP; Hicks KO; Wang J
    Adv Exp Med Biol; 2014; 772():111-45. PubMed ID: 24272357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Target Gene Discovery for Novel Therapeutic Agents in Cancer Treatment.
    Tiwari S; Ammerpohl O; Kalthoff H
    Methods Mol Biol; 2016; 1381():181-200. PubMed ID: 26667461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ratiometric fluorescent probes for selective and sensitive visualization of bacterial microenvironment protease activity.
    Wang Q; Wang X; Sun Y; Yang X; Zhang L; Zhang Q; Hu ZQ; Hu HY
    Chem Commun (Camb); 2019 Apr; 55(35):5064-5067. PubMed ID: 30896004
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative analysis of autophagy using advanced 3D fluorescence microscopy.
    Changou CA; Wolfson DL; Ahluwalia BS; Bold RJ; Kung HJ; Chuang FY
    J Vis Exp; 2013 May; (75):e50047. PubMed ID: 23665532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro.
    Lee JM; Mhawech-Fauceglia P; Lee N; Parsanian LC; Lin YG; Gayther SA; Lawrenson K
    Lab Invest; 2013 May; 93(5):528-42. PubMed ID: 23459371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Three-Dimensional Tissue Models and Available Probes for Multi-Parametric Live Cell Microscopy: A Brief Overview.
    O'Donnell N; Dmitriev RI
    Adv Exp Med Biol; 2017; 1035():49-67. PubMed ID: 29080130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Controlled extracellular proteolysis of thrombospondins.
    Carminati L; Carlessi E; Longhi E; Taraboletti G
    Matrix Biol; 2023 May; 119():82-100. PubMed ID: 37003348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid and automated multidimensional fluorescence microscopy profiling of 3D human breast cultures.
    Park CC; Georgescu W; Polyzos A; Pham C; Ahmed KM; Zhang H; Costes SV
    Integr Biol (Camb); 2013 Apr; 5(4):681-91. PubMed ID: 23407655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bright quantum dots emitting at ∼1,600 nm in the NIR-IIb window for deep tissue fluorescence imaging.
    Zhang M; Yue J; Cui R; Ma Z; Wan H; Wang F; Zhu S; Zhou Y; Kuang Y; Zhong Y; Pang DW; Dai H
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):6590-6595. PubMed ID: 29891702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Addressing the tumour microenvironment in early drug discovery: a strategy to overcome drug resistance and identify novel targets for cancer therapy.
    Kaemmerer E; Loessner D; Avery VM
    Drug Discov Today; 2021 Mar; 26(3):663-676. PubMed ID: 33278601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interrogating the Impact of Protease Activity on Tumor Progression Using 3D Spheroid Models.
    Gibson SV; Carter EP; Grose RP
    Methods Mol Biol; 2024; 2747():177-188. PubMed ID: 38038941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exploring Drug Dosing Regimens In Vitro Using Real-Time 3D Spheroid Tumor Growth Assays.
    Lal-Nag M; McGee L; Titus SA; Brimacombe K; Michael S; Sittampalam G; Ferrer M
    SLAS Discov; 2017 Jun; 22(5):537-546. PubMed ID: 28298153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
    Meier-Hubberten JC; Sanderson MP
    Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stretching the timescale of intravital imaging in tumors.
    Gligorijevic B; Condeelis J
    Cell Adh Migr; 2009; 3(4):313-5. PubMed ID: 19786830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.